Supervised In-Center Eye Exercises for Parkinson's (NCT07525973)
Improve balance through eye exercises
- Trial ID
- NCT07525973
- Official Title
- The Effect of Eye Exercises on Physical Function, Balance, and Fall Risk in Patients With Parkinson's Disease: A Randomized Controlled Trial
- Goal
- Improve balance through eye exercises
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Pardis Specialized Wellness Institute
- Study Type
- INTERVENTIONAL
- Enrollment
- 34 participants
- Conditions
- Parkinson Disease
- Interventions
- Supervised In-Center Eye Exercises
Summary For Families
They want to see if guided eye exercises can improve physical function, steadiness, and lower fall risk by helping the eyes and brain better guide balance and stepping. The treatment is supervised in-center eye exercises that train gaze stability, visual tracking, and visual-motor coordination so your eyes, head, and body work together more smoothly; it is non-drug and does not change levodopa or other Parkinson meds, participants just need to be on a stable regimen. Looking for adults 18 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can stand and walk (with or without a device) and attend sessions. People with severe cognitive or visual impairment, unstable heart or other acute medical problems, or changing Parkinson medications are excluded.
Locations
- Pardis specialized wellness institute, Isfahan, Iran
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Supervised In-Center Eye Exercises. They want to see if guided eye exercises can improve physical function, steadiness, and lower fall risk by helping the eyes and brain better guide balance and stepping. The treatment is supervised in-center eye exercises that train gaze stability, visual tracking, and visual-motor coordination so your eyes, head, and body work together more smoothly; it is non-drug and does not change levodopa or other Parkinson meds, participants just need to be on a stable regimen. Looking for adults 18 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who can stand and walk (with or without a device) and attend sessions. People with severe cognitive or visual impairment, unstable heart or other acute medical problems, or changing Parkinson medications are excluded.
- Who can participate?
- Participants must be between 18 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- You will attend supervised in-center sessions lasting approximately 30 to 45 minutes, 3 sessions per week for 8 weeks.